|
|
|
Insider
Information: |
Baker G Leonard Jr |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,066,812 |
|
Indirect Shares
|
10,825,897 |
|
|
Direct
Value |
$28,805,590 |
|
|
Indirect Value
|
$117,517,021 |
|
|
Total
Shares |
11,892,709 |
|
|
Total
Value |
$146,322,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
15
|
1
|
Stock
price went up :
|
10
|
1
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
1.0
|
Percentage
Gain/Loss : |
13.8%
|
72.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2014-06-12 |
7,981 |
2014-06-12 |
2,633,587 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2023-07-17 |
1,046,631 |
2023-07-17 |
4,263,565 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
10% Owner |
2006-02-08 |
8,360 |
2014-01-01 |
3,790,923 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
3,840 |
2014-10-01 |
132,161 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
5,661 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
Director |
|
2013-12-31 |
5 |
A |
$0.00 |
$0 |
I/I |
87,131 |
1,961,119 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
1,961,119 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-05-09 |
4 |
B |
$1.84 |
$184,290 |
D/D |
100,000 |
578,389 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-06-11 |
4 |
B |
$2.32 |
$239,856 |
I/I |
103,386 |
830,978 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-20 |
4 |
OE |
$2.77 |
$1,838,964 |
I/I |
663,886 |
1,061,819 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-20 |
4 |
S |
$5.85 |
$1,838,983 |
I/I |
(314,356) |
952,513 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-27 |
4 |
OE |
$4.05 |
$1,730,164 |
I/I |
427,201 |
954,109 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-31 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-06-30 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
543,110 |
955,009 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-08-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,509,043) |
280,365 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-09-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(280,365) |
0 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
27,641 |
955,055 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-01-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-06 |
4 |
B |
$4.79 |
$211,886 |
D/D |
44,200 |
721,038 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-09 |
4 |
B |
$4.88 |
$128,380 |
D/D |
26,302 |
747,340 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-10 |
4 |
B |
$5.00 |
$147,629 |
D/D |
29,498 |
776,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-09-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-11-13 |
4 |
S |
$17.59 |
$527,556 |
D/D |
(30,000) |
776,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-11-13 |
4 |
OE |
$2.70 |
$81,000 |
D/D |
30,000 |
806,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-05-11 |
4 |
S |
$16.01 |
$480,312 |
D/D |
(30,000) |
776,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-05-11 |
4 |
OE |
$2.23 |
$66,900 |
D/D |
30,000 |
806,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-14 |
4 |
B |
$12.47 |
$1,247,000 |
D/D |
100,000 |
876,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-15 |
4 |
B |
$12.49 |
$994,967 |
I/I |
79,686 |
2,693,320 |
2.1 |
- |
|
174 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|